newsfilter
← Latest News
ACCESS Newswire·

CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

HOUSTON, TX / ACCESSWIRE / November 1, 2024 / CNS Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the development of novel treatments for